Login / Signup

Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate Biopsies.

Edward C F WilsonAlice WrefordPriya TamerKelly LeonardHannah BrechkaVincent J Gnanapragasam
Published in: PharmacoEconomics - open (2021)
Transperineal biopsy devices may be cost effective compared with transrectal biopsy at per-procedure acquisition costs below £81 and cost-neutral if under £41. Future research is required to confirm or refute these findings, particularly randomised comparisons of the diagnostic accuracy and infection risks between the methods.
Keyphrases
  • ultrasound guided
  • fine needle aspiration
  • prostate cancer
  • clinical trial
  • open label
  • current status
  • minimally invasive
  • double blind
  • benign prostatic hyperplasia
  • risk assessment
  • climate change